1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Metastatic BRCA Hereditary Breast Carcinoma: new trials by email Literature Review of Metastatic BRCA Hereditary Breast Carcinoma trials Research Report on Metastatic BRCA Hereditary Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer Dostarlimab, Niraparib, Biopsy - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 1 | Active not recruiting | University of Washington | 18 | 2021-10-18 | 2026-08-20 |
| Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases Cisplatin, Laboratory Biomarker Analysis, Placebo Administration - Metastatic BRCA Hereditary Breast Carcinoma, Metastatic Breast Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 344 | 2016-09-15 | 2026-04-08 |
Breast Neoplasms (2) · Brain Neoplasms (1) · Fallopian Tube Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Adnexal Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Fallopian Tube Diseases (1) · Female Urogenital Diseases (1)
1,2-diaminocyclohexaneplatinum II citrate (1) · Biopsy (1) · Cisplatin (1) · Disulfides (1) · Immunoglobulin G (1) · Magnetic Resonance Spectroscopy (1) · Platinum (1) · dostarlimab (1) · niraparib (1) · veliparib (1)
National Cancer Institute (NCI) (1) · University of Washington (1)
United States (2) · Puerto Rico (1)
Elizabeth M. Swisher (1) · Eve T Rodler (1)
U10CA180888 (1)